Cardiovascular Safety Assessment in Cancer Drug Development

The development of cardiovascular toxicity attributable to anticancer drugs is a pivotal event that is associated with cardiovascular morbidity as well as with worse cancer‐specific and overall outcomes. Although broad consensus exists regarding the importance of cardiovascular safety assessment in...

Descripción completa

Detalles Bibliográficos
Autores principales: Oren, Ohad, Neilan, Tomas G., Fradley, Michael G., Bhatt, Deepak L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Contemporary Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075223/
https://www.ncbi.nlm.nih.gov/pubmed/34913360
http://dx.doi.org/10.1161/JAHA.121.024033

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075223/
https://www.ncbi.nlm.nih.gov/pubmed/34913360
http://dx.doi.org/10.1161/JAHA.121.024033

Ejemplares similares